NCT06809010 grouP O wholE blooD : storagE leSion impacT And infLammation
| NCT ID | NCT06809010 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Etablissement Français du Sang |
| Condition | Blood Donation |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-03-12 |
| Primary Completion | 2028-02 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
"Etablissement Français du Sang" (EFS) prepares labile blood products from blood donations that are separated by type (red blood cells, plasma and platelets). The "Centre de Transfusion Sanguine des Armées" (CTSA) produces an innovative labile blood product, LTO-WB, corresponding to group O leukocyte-free whole blood. The objective of the PEDESTAL EFS study is to compare the inflammatory and biological characteristics of blood products prepared by the EFS vs. the labile blood product prepared by the CTSA.
Eligibility Criteria
Inclusion Criteria: Self-referred donors eligible for blood donation (whole blood and/or platelet/plasma apheresis), meeting the following inclusion criteria: * Be in good health * Weigh at least 50 kg * Must be between 18 and 70 years of age for whole blood donation and between 18 and 65 years of age for plasma/platelet donation by apheresis. Exclusion Criteria: Subjects ineligible to donate blood